Preise:
2012Clinical Excellence Award, University Hospital of Southampton NHS Foundation Trust
2007Pfizer Prize in Rheumatology/Immunology, Basic science (Zürich)
2003 Max Cloëtta 5-year fellowship (Max Cloëtta assistant professorship)
2003SCORE fellowship (Swiss National Science Foundation)
2002Preis für beste Postervorstellung, Swiss Rheumatology Congress Montreux (2002)
20003rd Prize, Young Master's Tournament of the Deutsche Gesellschaft für Innere Medizin ('Novel Immunodeficiency Syndrome with Resemblance to Wegener's Granulomatosis”; Wiesbaden, Germany)
Publikationen:
Über 60 wissenschaftliche Originalartikel, Reviews und Buchkapitel mit Impact Factor aller Originalartikel >420 (Durchschnitt 9.5/Artikel); H-Index 24.
Wichtigste Publikationen in Fachzeitschriften:
Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules. Lancet 1999, 354:1598-603.
Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000, 287:1031.
Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci USA 2001, 98:3294-8
Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. Nat Immunol 2002, 3:721-6.
The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat Immunol 2005, 6:819-26.
Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J Exp Med 2006, 203:2293-303.
Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors. J Exp Med 2006, 203:699-710.
Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med 2007, 356:1410-22.
Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 2008, 67:84-90.
Virus infection, asthma, and chronic obstructive pulmonary disease. N Engl J Med 2008, 359:2062-4.
Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop. PLoS Biol 2010; 8:e1000402.
Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 2011, 12:1202-11.
Vasculitis in 2011 – The renaissance of granulomatous inflammation in AAV. Nat Rev Rheum 2012, 8:74-6.
Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. J Allergy Clin Immunol, 2014 133:1420-8.
Structural and Functional Changes of the Invariant NKT Clonal Repertoire in Early Rheumatoid Arthritis. J Immunol 2015, 195:5582-91.
Cholesteryl esters stabilise human CD1c conformations for recognition by self-reactive T cells. Proc Natl Acad Sci USA 2016;113(9):E1266-75.
The clonal iNKT cell repertoire in people with type 1 diabetes is characterized by a loss of clones expressing high-affinity TCRs. J Immunol 2017; 198:1452-1459.
CD1b-restricted GEM T cell responses are modulated by Mycobacterium tuberculosis mycolic acid meromycolate chains. Proc Natl Acad Sci USA 2017; 114:E10956-E10964.
Multitissue Transcriptomics Delineates the Diversity of Airway T Cell Functions in Asthma. Am J Respir Cell Mol Biol 2018. 2018; 58:261-270.
Buchkapitel:
Gadola S, Villiger P.M (2006). Konnektivitiden und Vaskulitiden („Connective tissue diseases and Vasculitides“) (p.74 - 115). In „Rheumatologie in Kürze -Klinisches Basiswissen für die Praxis“. Thieme Verlag, Stuttgart.
Gadola SD (2012). Einführung in das Immunsystem (Seite 3 – 76) im Textbuch „Klinische Immunologie“ (Editors: Peter, Pichler, Ladner). Elsevier Urban & Fischer Verlag 2012. ISBN 978-3-437-23256-5.
